Kolinsky Wealth Management LLC bought a new position in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) in the third quarter, Holdings Channel reports. The firm bought 1,368 shares of the medical research company’s stock, valued at approximately $203,000.
Other large investors also recently made changes to their positions in the company. B. Riley Wealth Advisors Inc. lifted its stake in Agilent Technologies by 47.9% in the first quarter. B. Riley Wealth Advisors Inc. now owns 5,281 shares of the medical research company’s stock valued at $768,000 after buying an additional 1,711 shares during the period. Atria Investments Inc grew its holdings in Agilent Technologies by 26.6% during the first quarter. Atria Investments Inc now owns 11,841 shares of the medical research company’s stock valued at $1,723,000 after purchasing an additional 2,491 shares during the period. Cetera Investment Advisers increased its stake in Agilent Technologies by 953.3% in the first quarter. Cetera Investment Advisers now owns 32,694 shares of the medical research company’s stock valued at $4,757,000 after purchasing an additional 29,590 shares in the last quarter. Cetera Advisors LLC raised its holdings in Agilent Technologies by 45.7% in the first quarter. Cetera Advisors LLC now owns 13,620 shares of the medical research company’s stock worth $1,982,000 after purchasing an additional 4,274 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its position in shares of Agilent Technologies by 36.4% during the first quarter. EverSource Wealth Advisors LLC now owns 731 shares of the medical research company’s stock worth $100,000 after purchasing an additional 195 shares in the last quarter.
Insider Transactions at Agilent Technologies
In related news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. This represents a 19.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Analyst Ratings Changes
Read Our Latest Research Report on A
Agilent Technologies Price Performance
NYSE:A opened at $137.98 on Friday. The stock’s 50-day simple moving average is $137.60 and its 200 day simple moving average is $137.37. Agilent Technologies, Inc. has a 52-week low of $124.16 and a 52-week high of $155.35. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.37 and a current ratio of 2.09. The company has a market cap of $39.65 billion, a P/E ratio of 31.22, a P/E/G ratio of 4.38 and a beta of 1.07.
Agilent Technologies Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be given a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date is Tuesday, December 31st. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is 21.27%.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Further Reading
- Five stocks we like better than Agilent Technologies
- Buy P&G Now, Before It Sets A New All-Time High
- ServiceNow: Will the High-Flyer Finally Split in 2024?
- What is Forex and How Does it Work?
- MarketBeat Week in Review – 11/25 – 11/29
- 10 Best Airline Stocks to Buy
- These 3 Stocks Are Heavy Hitters in Alternative Asset Management
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.